Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 47.96B | 45.22B | 43.42B | 43.34B | 51.33B |
Gross Profit | 16.52B | 16.36B | 16.42B | 16.66B | 24.37B |
EBITDA | 3.60B | 3.71B | 4.04B | 4.65B | 4.69B |
Net Income | 1.40B | 1.80B | 2.18B | 2.70B | 2.51B |
Balance Sheet | |||||
Total Assets | 47.37B | 47.95B | 43.15B | 41.30B | 40.32B |
Cash, Cash Equivalents and Short-Term Investments | 15.82B | 15.23B | 18.50B | 16.75B | 16.29B |
Total Debt | 506.00M | 602.00M | 0.00 | 0.00 | 0.00 |
Total Liabilities | 13.15B | 15.13B | 12.22B | 12.22B | 13.26B |
Stockholders Equity | 34.22B | 32.82B | 30.93B | 29.08B | 27.06B |
Cash Flow | |||||
Free Cash Flow | 1.14B | -2.66B | 1.19B | 1.76B | 4.01B |
Operating Cash Flow | 4.53B | 767.00M | 2.81B | 3.33B | 4.74B |
Investing Cash Flow | -3.34B | -3.64B | -1.32B | -1.44B | -870.00M |
Financing Cash Flow | -645.00M | -468.00M | 265.00M | -1.69B | -1.23B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | ¥25.14B | 13.35 | ― | 16.73% | 80.15% | ||
70 Neutral | ¥24.79B | 9.58 | 1.84% | 2.09% | -8.76% | ||
65 Neutral | £10.16B | 8.27 | 3.35% | 288.96% | -1.42% | 18.13% | |
65 Neutral | ¥24.59B | 39.58 | 1.58% | -3.88% | -39.50% | ||
65 Neutral | ¥24.60B | 39.05 | 1.97% | 0.93% | 330.63% | ||
64 Neutral | ¥23.53B | 17.53 | 1.98% | 6.08% | -22.00% | ||
62 Neutral | ¥25.11B | 18.58 | 1.20% | 2.76% | -3.44% |